rs4452185
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004300.4(ACP1):c.294-634T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.301 in 152,144 control chromosomes in the GnomAD database, including 7,566 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.30 ( 7566 hom., cov: 33)
Consequence
ACP1
NM_004300.4 intron
NM_004300.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.18
Publications
3 publications found
Genes affected
ACP1 (HGNC:122): (acid phosphatase 1) The product of this gene belongs to the phosphotyrosine protein phosphatase family of proteins. It functions as an acid phosphatase and a protein tyrosine phosphatase by hydrolyzing protein tyrosine phosphate to protein tyrosine and orthophosphate. This enzyme also hydrolyzes orthophosphoric monoesters to alcohol and orthophosphate. This gene is genetically polymorphic, and three common alleles segregating at the corresponding locus give rise to six phenotypes. Each allele appears to encode at least two electrophoretically different isozymes, Bf and Bs, which are produced in allele-specific ratios. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Aug 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.575 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ACP1 | ENST00000272065.10 | c.294-634T>C | intron_variant | Intron 4 of 5 | 1 | NM_004300.4 | ENSP00000272065.5 |
Frequencies
GnomAD3 genomes AF: 0.301 AC: 45787AN: 152026Hom.: 7572 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
45787
AN:
152026
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.301 AC: 45787AN: 152144Hom.: 7566 Cov.: 33 AF XY: 0.304 AC XY: 22594AN XY: 74358 show subpopulations
GnomAD4 genome
AF:
AC:
45787
AN:
152144
Hom.:
Cov.:
33
AF XY:
AC XY:
22594
AN XY:
74358
show subpopulations
African (AFR)
AF:
AC:
7593
AN:
41540
American (AMR)
AF:
AC:
4113
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
1114
AN:
3470
East Asian (EAS)
AF:
AC:
3066
AN:
5174
South Asian (SAS)
AF:
AC:
1298
AN:
4816
European-Finnish (FIN)
AF:
AC:
4195
AN:
10562
Middle Eastern (MID)
AF:
AC:
103
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23437
AN:
67982
Other (OTH)
AF:
AC:
634
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1604
3208
4813
6417
8021
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1282
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.